Cheryl Cole out of intensive care

Cheryl Cole has left intensive care and has been transferred to a private clinic in London. The singer, who has been battling the potentially deadly disease malaria, was transferred to University College London Hospital, which is home to the Hospital...

Cheryl Cole has left intensive care and has been transferred to a private clinic in London.

The singer, who has been battling the potentially deadly disease malaria, was transferred to University College London Hospital, which is home to the Hospital for Tropical Diseases, in the centre of the capital.

A statement issued on Ms Cole's behalf said: "Cheryl Cole today came out of intensive care and has left UCLH. She has now been transferred to a private clinic where she will remain for her recovery."

The 27-year-old X-Factor judge contracted malaria on a trip last month to Tanzania - which is home to one of the most dangerous strains of malaria - despite taking tablets. The singer and close friend Derek Hough spent six days together on Africa's east coast following her split from England footballer Ashley.

Ms Cole, who has been supporting Black Eyed Peas on tour, is reported to have collapsed with suspected gastroenteritis during a photoshoot for her album last Saturday afternoon, when she was initially diagnosed with exhaustion. But she was rushed to hospital the next day after her symptoms, including a soaring fever, worsened.

The in-demand star already had several work commitments on the near horizon, including next month's V Festival, as well as her X-Factor duties.

Malaria is caused by the parasite plasmodium, which is transmitted by the bites of infected mosquitos. If not treated promptly, it can become life-threatening by disrupting the blood supply to vital organs. Nine people die on average in the UK each year from malaria.

Sign up to our free newsletters

Get the best updates straight to your inbox:

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.